wellness
Springfield, Oregon–(Newsfile Corp. – June 14, 2023) – Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) (“Silo” or “the Company”), a pioneer in psilocybin wellness retreats, is excited to announce its feature this Sunday on a groundbreaking CNN documentary episode of The Whole Story with Anderson Cooper. The episode, entitled ‘Magic Mushrooms: Can They Change Your Mind?’ takes […]
Endexx Announces 10K/A Audited Consolidated Fiscal 2022 Financial Results
Endexx Year Over Year Annual Revenues Grew 229% CAVE CREEK, AZ, June 12, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Endexx® Corporation (OTC: EDXC), a provider of innovative plant-based wellness and nutritional products, today announced the filing of its amended, consolidated, audited fiscal 2022 annual report. Endexx reported the consolidated 10-K audited revenue has grown 229% percent […]
Relationship Set to Accelerate ADHC’s Brands into the $59 Billion CBD Market Del Mar, California–(Newsfile Corp. – April 5, 2023) – American Diversified Holdings Corporation (OTC Pink: ADHC) is pleased to announce today that the company, through it’s brands UNIVERSAL WELLNESS and Amazon vendor ROLLSCHOICE, has reached a comprehensive alliance with GGII’s leading group […]
Doseology Announces CEO Transition
Kelowna, British Columbia, March 31, 2023 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, announces the resignation of Ralph Olson as Chief Executive Officer and Director of the Company. Pratik (Tiki) Patel has been appointed interim CEO. Mr. Patel is a Chartered Professional Accountant […]
Partnership with Atlas to focus on U.S. market with immediate sales and marketing of U.S. Government approved products and laboratory collaboration to secure further FDA approvals VANCOUVER, BC / ACCESSWIRE / December 19, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, a medical […]
Captiva Verde Wellness Corp Announces Private Placement
Coquitlam, British Columbia–(Newsfile Corp. – November 22, 2022) – Captiva Verde Wellness Corp. (CSE: PWR) (OTC Pink: CPIVF) (the “Company or Captiva“) is pleased to announce that it has arranged a non-brokered private placement of 20,000,000 units at CDN $0.02 per unit for CDN $400,000.00. Each unit comprises one common share and one five-year whole share purchase […]
Irwin Naturals Completes Georgia Acquisition, Adds Two Ketamine Clinics to National Chain
The national chain of psychedelic mental-healthcare clinics growing rapidly LOS ANGELES, Aug. 08, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) completed the acquisition of two ketamine clinics in Georgia through an asset purchase of Invictus Clinics, LLC, which will be brought into the fast-growing national chain of psychedelic […]
Irwin Naturals Expands Operations into Northeast with Acquisition of Vermont-Based Clinic
Company continues national growth trajectory for Emergence clinics focusing on total wellness including the therapeutic use of ketamine LOS ANGELES, June 17, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has entered into a binding agreement to acquire the assets of Hobie Fuerstman D O […]
TripSitter.Clinic Launches New App for At-Home Ketamine Therapy
TORONTO, June 3, 2022 /CNW/ – TripSitter Clinic Ltd. (CSE: KETA) (FSE: UY0) (“TripSitter” or the “Company”), today announced the official launch of the TripSitter App, a simple and free App that makes it easy for users to access TripSitter Clinics’ services. TripSitter.Clinic Launches New App for At-Home Ketamine Therapy (CNW Group/TripSitter Clinic Ltd.) CEO of TripSitter […]
JUPITER, FL / ACCESSWIRE / April 18, 2022 /Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that it has appointed three sales and marketing executives to its team to drive sales of its science-backed proprietary brands and products. Over the past two years, Jupiter has built a portfolio of award-winning wellness brands including CaniSun, fitCBD, Jack, Wellness CBD […]
Hemp for Health Consolidates Its Share Capital
Vancouver, British Columbia–(Newsfile Corp. – November 29, 2021) – Further to its news release of November 17, 2021, HEMP FOR HEALTH INC. (CSE: HFH) (FSE: 9HH) (the “Company”) announces that effective at the opening of trading on Thursday, December 2nd, 2021 (the “Effective Date”) the shares of the Company will commence trading on the Canadian Securities […]
Ehave Looks to Power the Psychedelics Revolution
Mental illness will cost the global economy $16 trillion by 2030 due to early-onset and lost productivity, with an estimated 12 billion working days lost due to these conditions each year. Conventional therapies have a mixed track record, but psychedelics have shown much promise in recent years. The challenge for researchers and medical professionals is […]
TORONTO, June 15, 2021 /CNW/ – Canada House Wellness Group (CSE: CHV) (“Canada House” or the “Company“), a fully integrated medical cannabis company, is pleased to announce that its wholly owned subsidiary, Abba Medix Corp. (“Abba“) has surpassed 900 active medical patient registrations. Abba has experienced accelerated patient growth over the past 6 months with active medical patient […]
Psychedelics Wellness Company Delic: Proven Management Team with a Star-Studded Board
The psychedelics sector is quickly evolving into a multi-billion-dollar industry with a growing number of publicly traded companies. As with any new industry, there are many companies backed by little more than financiers looking to make a quick dollar before moving on to the next opportunity, which makes it important for investors to know who’s […]
Ovation Science Takes Topical Cannabis to the Next Level with Its Patented Drug Delivery Technology
Cannabinoids have become some of the most popular health and wellness products in the world. For example, CBD-infused topicals are expected to reach $4.5 billion in sales by 2025, according to Cultivating Wellness, which represents a 540% increase since 2020. At the same time, topicals infused with THC or combinations of CBD and THC are […]
There’s no Magic Answer to the Question, “Can I Patent Magic Mushrooms?”
“Patent pending” is a phrase you are likely familiar with. You have seen it stamped on the side of some doodad at the mall or heard it on the TV show that you are binge watching, and you think to yourself, “Wow, I wish I could invent something that everyone thinks is really cool”. Most […]
Psychedelic Clinical Trials & Who’s Behind Them
The psychedelics industry has experienced unprecedented growth over the past few years, driven by a combination of emerging research, regulatory support and investor interest. With a growing number of organizations in the space, it can be difficult for investors to keep track of what clinical trials are ongoing and what opportunities lie in the horizon. […]
Revive Therapeutics Aims to Bring Psychedelics to Market
The psychedelic drug market is projected to grow at a 16.3% compound annual growth rate to reach nearly $7 billion by 2027, according to Data Bridge Market Research. While there are a growing number of publicly traded companies in the space, the best opportunities have the right combination of experience, intellectual property and clinical trials. […]
Psychedelics: Significant Investor Interest Despite the Pandemic
The COVID-19 pandemic may be ravaging large swaths of the economy, but the stock market has consistently hit new record highs. After spending several years under-the-radar, the psychedelics industry is experiencing a renaissance driven by a combination of FDA-driven catalysts and soaring investor interest in a new class of potential blockbuster therapeutics. Let’s take […]
Royalty Streaming: A Different Way to Get Exposure to the Cannabis Market
When cannabis legalization started to gain momentum in 2012 with Washington and Colorado legalizing recreational marijuana, everyone knew it was going to be a big industry. For nearly a decade now, the investment community has ridden the volatility of the emerging market that generated $13.8 billion in sales in North America in 2019. Analysts […]
CBD Innovator, HempFusion, Makes Successful Debut on TSX
HempFusion Wellness Inc. (TSX: CBD-U) shares soared over 65% following their successful debut on the Toronto Stock Exchange (TSX) on Wednesday, January 6, 2021. Cannabidiol, or CBD, has become one of the most popular health and wellness products in the world over the past couple of years. According to Research and Markets, the global […]
HempFusion Gears Up for IPO on the TSX
HempFusion Wellness Inc., a leading health and wellness CBD company, recently closed the order book for its proposed initial public offering (IPO), marking another step closer to becoming a publicly-traded company on the Toronto Stock Exchange (TSX) over the coming months. Completion of this proposed initial public offering has the potential to accelerate the company’s […]
Why Focus on Cannabis & Mushroom Extracts?
Cannabis extracts are poised to become a $28.5 billion market by 2027, according to Grand View Market Research, representing a 16.6% compound annual growth rate. At the same time, the functional mushroom market is forecast to reach $34.3 billion by 2024, which represents a respectable 8% compound annual growth rate. Let’s take a look […]
CBD Makes Its Way into Mainstream Retail
The U.S. market for CBD products is projected to reach $23.7 billion by 2023, according to Brightfield Group, representing a seven-fold increase in the market’s size. While it’s one of the fastest-growing subsets of the multi-trillion-dollar wellness industry, CBD products remain absent from most mass-market retailers. CVS became the first large-scale retailer to offer CBD […]
CB Therapeutics: Producing Rare Cannabinoid & Psychedelic Molecules at Scale
The cannabis industry has evolved from the legalization of dried cannabis to an increasingly detailed understanding of individual cannabinoids. While THC and CBD are the two most common, researchers are increasingly interested in CBC, THCV and other rare cannabinoids that could have specific and desirable effects on certain medical indications. The problem is that these […]
3 Psychedelische Business Modelle (und was am besten für Investoren ist)
Die Psychedelikaindustrie hat das Interesse von Pharmaunternehmen geweckt, die nach sichereren und effektiveren Produkten suchen, um ungedeckte medizinische Bedürfnisse im Bereich der psychischen Gesundheit zu befriedigen. Während psychedelische Moleküle vielversprechend sind, verlangen die Pharmahersteller, dass die Moleküle durch wissenschaftliche Techniken verbessert werden, um bestimmte therapeutische Ziele zu erreichen und Toxizitäten zu reduzieren. Es gibt drei […]
3 Psychedelic Business Models (and What’s Best for Investors)
The psychedelics industry has captured the interest of pharmaceutical companies seeking safer and more effective products to address unmet medical needs in mental health. While psychedelic molecules have shown promise, pharmaceutical manufacturers are likely to require that the molecules be improved through scientific engineering to meet specific therapeutic goals and reduce toxicities. There are three […]
DENVER, Colorado, USA – September 30th, 2020 – Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”) is pleased to announce that its subsidiary Mindleap Health (“Mindleap”), a digital telehealth mobile application for mental coaching and wellbeing, has officially launched and is available for download today: Download on Android Download on IOS […]
MindLeap Health Enters into Fast-Growing Telehealth Market
The COVID-19 pandemic has led to dramatic changes in healthcare. In addition to mobilizing a vaccine in record time, the pandemic could permanently alter the way that many people seek medical care, shifting from in-person to telehealth. These changes have created an enormous opportunity for companies to innovate in the remote delivery of health services. […]
Christina Lake Cannabis: Disrupting the Market with Ultra-Low Cost Production
Cannabis is quickly moving from a hot commodity to a regular commodity as a growing number of licensed producers put pressure on prices. While the government hopes that falling prices push out black market competition, many companies have seen their margins contract after just a short time in production—spelling danger for investors in the space. […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Creso was created to bring pharmaceutical expertise and methodological rigour to the world of cannabis and deliver quality products to people and animals everywhere.
Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the ACMPR and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada . Delta 9’s shares trade on the TSX Venture Exchange under the symbol “NINE”.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
